CODX (STOCKS)
Co-Diagnostics, Inc. Common Stock
$1.409600
+0.039600 (+2.89%)
Prev close: $1.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Dwight Howard Egan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.22M
- Employees
- 132
- P/E (TTM)
- -0.05
- P/B (TTM)
- 0.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-3.64 | $-3.67 | +0.0320 | +0.87% |
|
Sep 2025 (Q3)
|
$-4.80 | $-4.90 | +0.0960 | +1.96% |
|
Jun 2025 (Q2)
|
$-6.90 | $-18.97 | +12.0720 | +63.63% |
|
Mar 2025 (Q1)
|
$-7.20 | $-10.10 | +2.8980 | +28.70% |
Financial Statements
| Revenues | $622.49K |
| Benefits Costs and Expenses | $49.13M |
| Cost Of Revenue | $222.38K |
| Costs And Expenses | $49.13M |
| Gross Profit | $400.11K |
| Nonoperating Income/Loss | $1.65M |
| Operating Expenses | $50.57M |
| Depreciation and Amortization | $1.11M |
| Research and Development | $19.14M |
| Other Operating Expenses | $30.32M |
| Operating Income/Loss | -$50.17M |
| Income/Loss From Continuing Operations After Tax | -$46.90M |
| Income/Loss From Continuing Operations Before Tax | -$48.51M |
| Income Tax Expense/Benefit | -$1.62M |
| Net Income/Loss | -$46.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$46.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$46.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$35.25 |
| Diluted Earnings Per Share | -$35.25 |
| Basic Average Shares | 1,330,200 |
| Diluted Average Shares | 1,330,200 |
| Assets | $24.74M |
| Current Assets | $13.69M |
| Inventory | $992.40K |
| Other Current Assets | $12.70M |
| Noncurrent Assets | $11.05M |
| Fixed Assets | $2.27M |
| Intangible Assets | $7.22M |
| Other Non-current Assets | $1.56M |
| Liabilities | $4.11M |
| Current Liabilities | $3.54M |
| Accounts Payable | $1.88M |
| Other Current Liabilities | $1.66M |
| Noncurrent Liabilities | $574.30K |
| Equity | $20.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $20.63M |
| Liabilities And Equity | $24.74M |
| Net Cash Flow From Operating Activities | -$29.14M |
| Net Cash Flow From Operating Activities, Continuing | -$29.14M |
| Net Cash Flow From Investing Activities | $26.27M |
| Net Cash Flow From Investing Activities, Continuing | $26.27M |
| Net Cash Flow From Financing Activities | $11.81M |
| Net Cash Flow From Financing Activities, Continuing | $11.81M |
| Net Cash Flow | $8.95M |
| Net Cash Flow, Continuing | $8.95M |
| Comprehensive Income/Loss | -$47.31M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.31M |
| Other Comprehensive Income/Loss | -$47.31M |
| Other Comprehensive Income/Loss Attributable To Parent | -$418.44K |